Insmed Overview
Insmed Target Price
Analysts' 12-month price predictions for INSM.
Get informed when a big investor buys or sells
+ FollowShare Price
$104.92
Average Target Price
$204.46
94.9% upside
94.9% upside13 analysts in the last 4 months
High: $245 | Low: $160
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-13 | Truist Financial | $185 | 76.3% upside |  |
| 2026-05-08 | Wells Fargo | $160 | 52.5% upside | |
| 2026-05-08 | GuggenheimVamil Divan | $226 | 115.4% upside | |
| 2026-04-16 | Guggenheim | $230 | 119.2% upside | |
| 2026-04-14 | RBC Capital | $216 | 105.9% upside | |
| 2026-04-10 | Raymond James | $200 | 90.6% upside | |
| 2026-04-08 | Mizuho Securities | $202 | 92.5% upside | |
| 2026-03-26 | H.C. Wainwright | $245 | 133.5% upside | |
| 2026-02-24 | Mizuho Securities | $204 | 94.4% upside | |
| 2026-02-20 | Morgan Stanley | $166 | 58.2% upside | |
| 2026-02-20 | Wells FargoTiago Fauth | $208 | 98.2% upside | |
| 2026-02-19 | Stifel Nicolaus | $205 | 95.4% upside | |
| 2026-02-19 | Mizuho SecuritiesGraig Suvannavejh | $211 | 101.1% upside | |
| 2026-01-27 | BarclaysEliana Merle | $231 | 120.2% upside | |
| 2026-01-22 | Roth Capital | $212 | 102.1% upside | |
| 2026-01-21 | RBC CapitalLeonid Timashev | $200 | 90.6% upside | |
| 2026-01-12 | Truist FinancialDanielle Brill | $205 | 95.4% upside | |
| 2026-01-08 | Morgan StanleyMaxwell Skor | $157 | 49.6% upside | |
| 2026-01-06 | UBS | $215 | 104.9% upside | |
| 2025-12-19 | Truist FinancialDanielle Brill | $202 | 92.5% upside | |
| 2025-12-18 | H.C. Wainwright | $230 | 119.2% upside | |
| 2025-12-18 | Cowen & Co. | $241 | 129.7% upside | |
| 2025-12-18 | Mizuho SecuritiesGraig Suvannavejh | $212 | 102.1% upside | |
| 2025-12-18 | Guggenheim | $221 | 110.6% upside | |
| 2025-12-18 | Wedbush | $203 | 93.5% upside | |
| 2025-12-18 | RBC CapitalLeonid Timashev | $195 | 85.9% upside | |
| 2025-12-18 | Wells Fargo | $195 | 85.9% upside | |
| 2025-12-18 | Wolfe ResearchAndy Chen | $167 | 59.2% upside | |
| 2025-12-16 | Wells FargoTiago Fauth | $234 | 123% upside | |
| 2025-12-16 | Cantor FitzgeraldOlivia Brayer | $230 | 119.2% upside | |
| 2025-12-10 | Jefferies | $269 | 156.4% upside | |
| 2025-12-04 | Redburn Partners | $263 | 150.7% upside | |
| 2025-12-01 | Mizuho SecuritiesGraig Suvannavejh | $256 | 144% upside | |
| 2025-10-31 | Goldman Sachs | $225 | 114.4% upside | |
| 2025-10-31 | RBC CapitalLeonid Timashev | $215 | 104.9% upside | |
| 2025-10-31 | UBSTrung Huynh | $223 | 112.5% upside | |
| 2025-10-31 | Wells Fargo | $217 | 106.8% upside | |
| 2025-10-29 | Mizuho SecuritiesGraig Suvannavejh | $196 | 86.8% upside | |
| 2025-10-28 | Cantor Fitzgerald | $192 | 83% upside | |
| 2025-10-14 | UBS | $194 | 84.9% upside | |
| 2025-10-01 | Evercore ISIGavin Clark-Gartner | $180 | 71.6% upside | |
| 2025-08-12 | Wells FargoTiago Fauth | $140 | 33.4% upside | |
| 2025-03-06 | UBS | $110 | 4.8% upside | |
| 2024-08-15 | Mizuho SecuritiesGraig Suvannavejh | $92 |  12.3% downside | |
| 2024-08-09 | Wells FargoTiago Fauth | $85 | 19% downside | |
| 2024-07-09 | GuggenheimVamil Divan | $95 | 9.5% downside | |
| 2024-07-01 | Truist FinancialNicole Germino | $88 | 16.1% downside | |
| 2024-06-25 | BarclaysLeon Wang | $90 | 14.2% downside | |
| 2024-06-21 | Evercore ISILiisa Bayko | $75 | 28.5% downside | |
| 2024-06-07 | Mizuho SecuritiesGraig Suvannavejh | $82 | 21.8% downside | |